Cytosystems Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Out of Business
Cytosystems General Information
Description
Developer of non-invasive diagnostic and stratification technologies designed to detect cancer varieties. The company's technologies focus on the diagnosis and prognosis of urological cancers, including bladder and prostate cancer, and deploys highly sensitive and specific antibody diagnostic, enabling medical practitioners to simple, inexpensive, and reliable alternatives to cystoscopies and other traditional invasive approaches.
Contact Information
Website
www.cytosystems.comCorporate Office
- 7 Queens Gardens
- Aberdeen AB15 4YD
- Scotland, United Kingdom
Corporate Office
- 7 Queens Gardens
- Aberdeen AB15 4YD
- Scotland, United Kingdom
Cytosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Out of Business | 01-Jan-2022 | Completed | Out of Business | |||
| 9. Later Stage VC | 13-Dec-2018 | Completed | Generating Revenue | |||
| 8. Grant | 19-Jul-2016 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jun-2015 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 18-Jul-2013 | Completed | Startup | |||
| 5. Early Stage VC | 23-Jul-2012 | Completed | Startup | |||
| 4. Early Stage VC | 19-Sep-2011 | Completed | Startup | |||
| 3. Early Stage VC | 06-Oct-2009 | Completed | Startup | |||
| 2. Early Stage VC | 31-Jan-2007 | Completed | Startup | |||
| 1. Early Stage VC | 25-Nov-2006 | Completed | Startup |
Cytosystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| D Ordinary | ||||||||
| D Ordinary | ||||||||
| D Ordinary | ||||||||
| D Ordinary | ||||||||
| Pref | ||||||||
| D Ordinary | ||||||||
| D Ordinary | ||||||||
| E Ordinary | ||||||||
| D Ordinary | 1,239 | $0.012766 | $165.37 | $165.37 | 1x | $165.37 | 0.19% | |
| C Ordinary | 477 | $0.012766 | $165.37 | $165.37 | 1x | $165.37 | 0.07% |
Cytosystems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cytosystems Patents
Cytosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202015211-D0 | Assay | Inactive | 25-Sep-2020 | ||
| GB-202015122-D0 | Assay | Inactive | 24-Sep-2020 | ||
| EP-4217746-A1 | Diagnosis of cancer by imaging flow cytometry | Inactive | 24-Sep-2020 | ||
| WO-2022064422-A1 | Diagnosis of cancer by imaging flow cytometry | Inactive | 24-Sep-2020 | ||
| GB-201613192-D0 | Filtration | Inactive | 29-Jul-2016 |
Cytosystems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cytosystems FAQs
-
When was Cytosystems founded?
Cytosystems was founded in 2006.
-
Where is Cytosystems headquartered?
Cytosystems is headquartered in Aberdeen, United Kingdom.
-
What is the size of Cytosystems?
Cytosystems has 8 total employees.
-
What industry is Cytosystems in?
Cytosystems’s primary industry is Diagnostic Equipment.
-
Is Cytosystems a private or public company?
Cytosystems is a Private company.
-
What is Cytosystems’s current revenue?
The current revenue for Cytosystems is .
-
How much funding has Cytosystems raised over time?
Cytosystems has raised $2.99M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
